Medplus HealthQ1 FY25

Medplus Health Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹608.85P/E: 34.7Market Cap: ₹7.3K CrSector: Retailing

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 2 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2
  • MedPlus expects significant growth in private label sales, currently at 15% of GMV, with a steady increase of around 1.5%-2% per quarter.
  • The company targets 20%+ top-line revenue growth for FY '25, with pharmacy revenue growing 24% year-on-year on a GMV basis.
  • Expansion continues with a target of adding around 600 new stores in FY '25, focusing on tier 2 cities and beyond, which currently contribute 36% of pharmacy revenues.
  • As new stores mature (less than 2 years old are ramping up), improved profitability and breakeven within 4-6 months are expected to drive volume and revenue growth.
  • Marketing spends are being optimized, focusing on private label brand awareness, which is expected to increase customer acceptance and sales.
  • The gross margin and operating EBITDA per store are expected to improve as the private label mix deepens and operational efficiencies increase.

See what Medplus Health management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • No explicit mention of current or future new fundraising through debt or equity is made in the provided transcript.
  • The management discussed ongoing operational activities, store expansions, and marketing spends but did not reference any plans for raising capital.
  • They emphasized controlling expenses and achieving profitability improvements without indicating any upcoming fundraising events.
  • No indications were given about issuing new equity or raising debt in the near term.
  • Investor relations contact information was provided, but no fundraising calls or updates were shared during this earnings call.

See what Medplus Health management said on order book — free account, 30 seconds.

Capex plans

  • No explicit mention of current or future capex or strategic investment plans is detailed in the provided transcript from the Q1 FY25 earnings call.
  • The company is focused on expanding its store network with a guidance of 600 new store openings for FY '25.
  • There is emphasis on the ramp-up and profitability of new stores, with 64% of stores breakeven within six months.
  • Marketing spends were notably high (INR 9.5 crores in Q1), mostly for promotions in Tamil Nadu and West Bengal, but this is not recurring.
  • No direct commentary on capital expenditure or strategic investments beyond store expansion and marketing initiatives.
  • Management mentioned monitoring store level ROE and profitability but did not specify capital expenditure plans.

Track Medplus Health — get its next earnings analysis in your feed

How does Medplus Health rank vs peers in Retailing?

Pro feature
ThisMedplus Health
Rev 2Mar 3

How does Medplus Health rank in Retailing?

Compare Medplus Health against every Retailing company (Q1 FY25) on revenue, margins and earnings-call signals.

View Retailing leaderboard →

Others in Retailing this season

  • Acetech E-Commerce (Q2 FY27)

    Revenue from Operations for the half year ended September 30, 2026 is ₹4,055.15 lakhs (Standalone) vs ₹3,986.48 lakhs for the same period in 2025…

  • Net Avenue (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026, is ₹132,043 thousand (~₹132.04 million), compared to ₹116,869 thousand (~₹116.87 million)…

  • On Door Concepts (Q2 FY27)

    EBITDA for the quarter**: ₹824.13 lakhs . Key results statement takeaways from On Door Concepts Ltd's Q2 FY27 results statement — and how it ranks against secto

  • Brainbees Solutions (Q2 FY27)

    Consolidated revenue for Q2 FY27 was INR 23,958 Mn, growing 14.1% YoY, the strongest growth in six quarters (Pages 12, 13, 35). Key investor presentation takeaw

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →